95 related articles for article (PubMed ID: 15845922)
1. Increased SH2-Bbeta content and membrane association in transgenic mice overexpressing GH.
Miquet JG; Sotelo AI; Bartke A; Turyn D
J Endocrinol; 2005 May; 185(2):301-6. PubMed ID: 15845922
[TBL] [Abstract][Full Text] [Related]
2. Desensitization of the JAK2/STAT5 GH signaling pathway associated with increased CIS protein content in liver of pregnant mice.
Miquet JG; Sotelo AI; Bartke A; Turyn D
Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E600-7. PubMed ID: 15899943
[TBL] [Abstract][Full Text] [Related]
3. Suppression of growth hormone (GH) Janus tyrosine kinase 2/signal transducer and activator of transcription 5 signaling pathway in transgenic mice overexpressing bovine GH.
Miquet JG; Sotelo AI; Bartke A; Turyn D
Endocrinology; 2004 Jun; 145(6):2824-32. PubMed ID: 15016718
[TBL] [Abstract][Full Text] [Related]
4. Increased sensitivity to GH in liver of Ames dwarf (Prop1df/Prop1df) mice related to diminished CIS abundance.
Miquet JG; Sotelo AI; Dominici FP; Bonkowski MS; Bartke A; Turyn D
J Endocrinol; 2005 Dec; 187(3):387-97. PubMed ID: 16423818
[TBL] [Abstract][Full Text] [Related]
5. Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-bbeta.
Rui L; Gunter DR; Herrington J; Carter-Su C
Mol Cell Biol; 2000 May; 20(9):3168-77. PubMed ID: 10757801
[TBL] [Abstract][Full Text] [Related]
6. Identification of SH2-bbeta as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2.
Rui L; Carter-Su C
Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7172-7. PubMed ID: 10377387
[TBL] [Abstract][Full Text] [Related]
7. SH2-B is required for growth hormone-induced actin reorganization.
Herrington J; Diakonova M; Rui L; Gunter DR; Carter-Su C
J Biol Chem; 2000 Apr; 275(17):13126-33. PubMed ID: 10777618
[TBL] [Abstract][Full Text] [Related]
8. Regulation of JAK2 protein expression by chronic, pulsatile GH administration in vivo: a possible mechanism for ligand enhancement of signal transduction.
Zhou Y; Wang X; Hadley J; Corey SJ; Vasilatos-Younken R
Gen Comp Endocrinol; 2005 Nov; 144(2):128-39. PubMed ID: 15993410
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton.
Rico-Bautista E; Negrín-Martínez C; Novoa-Mogollón J; Fernández-Perez L; Flores-Morales A
Exp Cell Res; 2004 Mar; 294(1):269-80. PubMed ID: 14980520
[TBL] [Abstract][Full Text] [Related]
10. Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling.
Rui L; Mathews LS; Hotta K; Gustafson TA; Carter-Su C
Mol Cell Biol; 1997 Nov; 17(11):6633-44. PubMed ID: 9343427
[TBL] [Abstract][Full Text] [Related]
11. Endoplasmic reticulum stress prolongs GH-induced Janus kinase (JAK2)/signal transducer and activator of transcription (STAT5) signaling pathway.
Flores-Morales A; Fernández L; Rico-Bautista E; Umana A; Negrín C; Zhang JG; Norstedt G
Mol Endocrinol; 2001 Sep; 15(9):1471-83. PubMed ID: 11518796
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D3 cannot revert desensitization of growth hormone (GH)-induced STAT5-signaling in GH-overexpressing mice non-calcemic tissues.
Sotelo AI; Miquet JG; González L; Bartke A; Turyn D
Growth Horm IGF Res; 2008 Apr; 18(2):148-56. PubMed ID: 17881271
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins.
Hansen JA; Lindberg K; Hilton DJ; Nielsen JH; Billestrup N
Mol Endocrinol; 1999 Nov; 13(11):1832-43. PubMed ID: 10551777
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone-regulated intracellular signaling in UMR 106 osteosarcoma cells.
Morales O; Lindgren U; Haldosén LA
J Bone Miner Res; 2000 Nov; 15(11):2284-90. PubMed ID: 11092411
[TBL] [Abstract][Full Text] [Related]
15. Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation.
Xie S; Wang Y; Liu J; Sun T; Wilson MB; Smithgall TE; Arlinghaus RB
Oncogene; 2001 Sep; 20(43):6188-95. PubMed ID: 11593427
[TBL] [Abstract][Full Text] [Related]
16. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
Tong W; Zhang J; Lodish HF
Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
[TBL] [Abstract][Full Text] [Related]
17. YXXL motifs in SH2-Bbeta are phosphorylated by JAK2, JAK1, and platelet-derived growth factor receptor and are required for membrane ruffling.
O'Brien KB; Argetsinger LS; Diakonova M; Carter-Su C
J Biol Chem; 2003 Apr; 278(14):11970-8. PubMed ID: 12551917
[TBL] [Abstract][Full Text] [Related]
18. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase.
Ram PA; Waxman DJ
J Biol Chem; 1997 Jul; 272(28):17694-702. PubMed ID: 9211920
[TBL] [Abstract][Full Text] [Related]
19. SH2-Bbeta is a Rac-binding protein that regulates cell motility.
Diakonova M; Gunter DR; Herrington J; Carter-Su C
J Biol Chem; 2002 Mar; 277(12):10669-77. PubMed ID: 11786545
[TBL] [Abstract][Full Text] [Related]
20. Termination of growth hormone pulse-induced STAT5b signaling.
Gebert CA; Park SH; Waxman DJ
Mol Endocrinol; 1999 Jan; 13(1):38-56. PubMed ID: 9892011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]